In SURMOUNT-1, adults with obesity (without diabetes) lost an average of 15.0%, 19.5%, and 20.9% of body weight with tirzepatide 5 mg, 10 mg, and 15 mg respectively over 72 weeks, compared to 3.1% with placebo
\n\n\n\n BPC-157 and mTOR Pathway Interactions \n\n\n\n More recent research has begun examining BPC-157s potential interactions with the mTOR (mechanistic target of rapamycin) signaling pathway a central regulator of cell growth, protein synthesis, and cellular repair
Then your first step should be injecting daily for at least 90 days straight
Bacteriostatic water has been established as a safe and efficient reagent for the reconstitution of peptides, however there are some possible caveats to consider
PubMed laboratory research record [PMID: 9403790] PubMed record related to this compound for laboratory literature review